Stephens & Co. Initiates Coverage On Apyx Medical with Overweight Rating, Announces Price Target of $8
Portfolio Pulse from richadhand@benzinga.com
Stephens & Co. analyst George Sellers has initiated coverage on Apyx Medical (NASDAQ:APYX) with an Overweight rating and a price target of $8.
July 14, 2023 | 11:47 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Apyx Medical has been given an Overweight rating by Stephens & Co. with a price target of $8.
The Overweight rating from Stephens & Co. indicates a positive outlook for Apyx Medical. The price target of $8 suggests that the analyst believes the stock has significant upside potential. This could lead to increased investor interest and a potential rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100